Literature DB >> 4812442

Hyperglucagonemia of renal failure.

G L Bilbrey, G R Faloona, M G White, J P Knochel.   

Abstract

Elevation of plasma glucagon concentration has been observed in starvation and illnesses associated with increased catabolism such as diabetes mellitus and severe infections. Thus, we examined plasma glucose, immunoreactive insulin (IRI, microunits per milliliter) and glucagon (IRG, picograms per milliliter) responses to a beef meal (1 g/kg body wt) and intravenous glucose (1.5 g/min for 45 min) in patients with chronic renal failure (CRF). After the beef meal (n = 6), plasma glucose did not change, IRI rose from 10.1+/-1.2 to 16.3+/-1.1 (P < 0.01), and IRG rose from a fasting value of 225+/-26 to 321+/-40 (P < 0.01) by 90 min (mean+/-SEM). Intravenous infusion of glucose in CRF patients resulted in significant elevations and prolonged disappearance of plasma glucose and insulin when compared to control subjects (P < 0.01). Glucose infusion failed to suppress elevated plasma glucagon concentrations to normal levels.6 wk of chronic hemodialysis in five patients resulted in normal plasma glucose and insulin responses to the same intravenous glucose load. In contrast, plasma glucagon concentration remained unchanged after hemodialysis and there was no correlation of plasma glucagon levels with carbohydrate intolerance.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812442      PMCID: PMC333066          DOI: 10.1172/JCI107624

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

Review 1.  THE REGULATION OF GROWTH HORMONE SECRETION.

Authors:  S M GLICK; J ROTH; R S YALOW; S A BERSON
Journal:  Recent Prog Horm Res       Date:  1965

2.  The carbohydrate intolerance of uremic patients.

Authors:  F B WESTERVELT; G E SCHREINER
Journal:  Ann Intern Med       Date:  1962-08       Impact factor: 25.391

3.  Mechanism of impaired glucose tolerance in uremia and experimental hyperazotemia.

Authors:  G T PERKOFF; C L THOMAS; J D NEWTON; J C SELLMAN; F H TYLER
Journal:  Diabetes       Date:  1958 Sep-Oct       Impact factor: 9.461

4.  Abnormal pancreatic alpha-cell function in bacterial infections.

Authors:  D M Rocha; F Santeusanio; G R Faloona; R H Unger
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  Role of insulin in glucose intolerance in uraemia.

Authors:  J D Briggs; K D Buchanan; R G Luke; M T McKiddie
Journal:  Lancet       Date:  1967-03-04       Impact factor: 79.321

6.  Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis.

Authors:  F Santeusanio; G R Faloona; J P Knochel; R H Unger
Journal:  J Lab Clin Med       Date:  1973-06

7.  The sad truth about hemodialysis in diabetic nephropathy.

Authors:  M Ghavamian; C F Gutch; K F Kopp; W J Kolff
Journal:  JAMA       Date:  1972-12-11       Impact factor: 56.272

8.  Potassium deficiency in chronic renal failure.

Authors:  G L Bilbrey; N W Carter; M G White; J F Schilling; J P Knochel
Journal:  Kidney Int       Date:  1973-12       Impact factor: 10.612

9.  Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism.

Authors:  P L Balestri; P Rindi; M Biagini; S Giovannetti
Journal:  Clin Sci       Date:  1972-04       Impact factor: 6.124

10.  Effect of chronic renal failure and hemodialysis on carbohydrate metabolism.

Authors:  C L Hampers; J S Soeldner; P B Doak; J P Merrill
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

View more
  31 in total

Review 1.  Uremic toxins.

Authors:  B D Cohen
Journal:  Bull N Y Acad Med       Date:  1975-12

2.  Urinary sodium and calcium in various dog models and relationship to endogenous plasma glucagon.

Authors:  C Bornhof; P O Schwille
Journal:  Urol Res       Date:  1977

3.  Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.

Authors:  S F Kuku; J B Jaspan; D S Emmanouel; A Zeidler; A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

4.  The role of the liver in glucagon metabolism.

Authors:  J B Jaspan; A H Huen; C G Morley; A R Moossa; A H Rubenstein
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

5.  Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model.

Authors:  V Soman; P Felig
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

6.  Effects of reduced renal mass and dietary protein intake on amino acid release and glucose uptake by rat muscle in vitro.

Authors:  H R Harter; I E Karl; S Klahr; D M Kipnis
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

7.  Carbohydrate metabolism and uraemia-mechanisms for glycogenolysis and gluconeogenesis.

Authors:  W H Hörl; J Stepinski; A Heidland
Journal:  Klin Wochenschr       Date:  1980-10-01

8.  Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Glucagon metabolism in the rat.

Authors:  D S Emmanouel; J B Jaspan; A H Rubenstein; A H Huen; E Fink; A I Katz
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

Authors:  R A DeFronzo; J D Tobin; J W Rowe; R Andres
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.